18 April 2019, Thursday

HALL 1

HALL 2

HALL 3

OPENING CEREMONY

 

 

 

OPENING CONFERENCE

 

Chair: Brian Leonard (Ireland)

Using Brain-based Phenotyping to Improve Discovery in Psychiatry
Carol Tamminga (USA)

 

 

 

SYMPOSIUM 1

 

Advancing Psychiatric Diagnosis And Therapeutics Using Artificial Intelligence (AI)
Moderators:Andrew Greenshaw (Canada), Marek Kubicki (USA)

AI in Psychiatry: Relevance of successful aging indicators
Bo Coa

AI and schizophrenia - current and future prospects
Ezgi İnce Guliyev

AI solutions for Bipolar Disorder: natural language and face recognition
Elvan Çiftçi  
 

PLENARY LECTURE 1

 

The inside out of the outside within: a role for epigenetics in mental disorder
Bart Rutten (Netherlands)

PLENARY LECTURE 2

 

The development, determinants and treatment of psychopathology in offspring of patients with bipolar disorder
Mannon Hillegers (Netherlands)

SYMPOSIUM 4

 

Neuroplasticity of the brain: Evidence and Management
Moderators:Carol Tammigna (USA), Ali Saffet Gönül

fMRI and Alcohol use Disorder
Michal Juhas (Canada)

How does depression affect the brain during adolescence?
Ali Saffet Gönül 

Low field magnetic stimulation as a new neuroprotective approach for neuropsychiatric disorders: evidence from animal studies
Yanboo Zhang (Canada)

rTMS in psychiatry practice
Abdullah Bolu 
 

SYMPOSIUM 5

 

A special but comprehensive review in addiction
Moderators:Mücahit Öztürk (TAP), Kültegin Ögel

New psychopharmacological treatments in addiction
Cüneyt Evren

Community-based approach to addiction treatment
Kültegin Ögel

The concept of rehabilitation in addiction
Rabia Bilici

Effective psychosocial in the treatment of addiction
Melike Şimşek

PLENARY LECTURE 4

 

Childhood anxiety disorders: Into adolescence and adulthood, diagnosis and difficulties in treatment
Bengi Semerci (TAP)

19 April 2019, Friday

HALL 1

HALL 2

HALL 3

WORKSHOP 2

 

Treatment approaches in psychiatric symptoms in Alzheimer's disease patients
Işın Baral Kulaksızoğlu

 

WORKSHOP 4

 

Development and Well-Being Assessment

A Diagnostic Interview for Child and Adolescent Mental Disorders
Onur Burak Dursun (TAP)
 

SYMPOSIUM 9

 

Recent advances in mood disorders: neurobiology, technology, and biomarkers
Moderators:Feyza Aricioglu (TAP), Kyooseob Ha
(South Korea)


Future of psychiatry: role of technology for depression
Xin-Min Li (Canada)

Development of multiple proteomic marker panel and predictive model for the onset and progress of mood disorders
Kyooseob Ha (South Korea)

Neurobiology of mood disorders focusing on neuroinflammation and future treatment strategies
Feyza Aricioglu (TAP)

Clinical implication of current brain image findings in bipolar disorder
Yuan-Hwa Chou (Taiwan)
 

PLENARY LECTURE 5

 

Chairs :Kürşat Altınbaş, Çiğdem Şahbaz

Psychosis spectrum disorder: From the genome to the exposome and to the phenome
Sinan Gülöksüz (Netherlands)
 

PLENARY LECTURE 6

 

Chairs :Kerim Munir (USA), Ibrahim Durukan

Developmental Coordination Disorder and its implication on treatment of ADHD and ASD
Yankı Yazgan

PLENARY LECTURE 7

 

Chairs :Kültegin Ögel, Kemal Sayar (TAP)

Problematic smartphone use and relations with psychopathology constructs
Jon Elhai (USA)

SYMPOSIUM 12

 

Diagnostic and Therapeutic Advances in Later in Life Neuropsychiatry
Moderators:Işın Baral Kulaksızoğlu, Weihong Song (Canada)

Early Recognition and Diagnosis of Neuropsychiatric Disorders in Dementia; An overview
Işın Baral Kulaksızoğlu

Artificial Intelligence to advance neuroscience of normal or abnormal aging Process
Bo Cao (Canada)

ADHD as a later in life Neuropsychiatric Disorder?
Bahadır Turan

Advances in the therapeutics of Dementia?
Weihong Song (Canada)

 

SYMPOSIUM 13

 

Principles and Advances in Stem Cell Therapy in Neuropsychiatric Disorders
Moderators :Erdem Tüzün

Psychiatric disease modeling by organoids through stem cells
Özge Sezin Somuncu

Recent Advances in Stem Cell-Based Therapeutics for Neurodegenerative Diseases
Erdem Tüzün

Clinical Implications of Stem Cell as Therapeutic Targeting in Schizophrenia and Other Psychotic Disorders
Ümit Haluk Yeşilkaya
 

PLENARY LECTURE 8

 

Chairs:Serdar Dursun (Canada) (TAP), Dost Öngür (USA)

Hippocampal pathology and its contribution to psychosis in schizophrenia
Carol Tamminga (USA)


 

SPECIAL SYMPOSIUM 2

 

Sadness, Depression, Emotions and Drugs
Moderators:Erol Göka

Emotion, Temperament and Mood
Erol Göka

Sadness, the most appropriate to us: inducing sadness, consuming depression
Murat Beyazyüz

Treatment-resistant depression, depression-resisting psychiatry
Hasan Kaya
 

PLENARY LECTURE 9

 

Chairs: Özgür Öner, Feyza Aricioglu (TAP)

Stress, glucocorticoids and memory: implications for treating fear-related disorders
Benno Roozendaal (Netherlands)

DOUBLE CONFERENCE

 

Psychiatry in the brain age
Moderators :Erol Göka, Serdar Dursun (Canada) (TAP)

Psychiatry between the brain and mind
Kazım Yazıcı

Does the brain explain everything? Neuromania and psychiatry
Kemal Sayar (TAP)

SYMPOSIUM 20

 

Paradigm shift in psychiatric neuroimaging studies
Moderators:Fei Wang (China), Yanqing Tang (China)

Diffusion MRS techniques and white matter biology in schizophrenia
Dost Öngür (USA)

Dopamine transporter and hippocampal volumes in schizophrenia
Yuan-Hwa Chou (Taiwan)

How analyzing big imaging data can help understanding time course of white matter pathology in schizophrenia
Marek Kubicki (USA)

The effects of emotions on learning in depressed patients: an fMRI study
Ali Saffet Gönül
 

SYMPOSIUM 21

 

Evidence based treatments in autism spectrum disorders
Moderators:Kerim Munir (USA), Onur Burak Dursun (TAP)

Evidence based treatment of challenging behaviors in ASD
Özgür Öner

Questions of severity, specifiers, and treatment challenges in complex autism spectrum disorders
Kerim Munir (USA)

Evidence based therapies and non-medical treatments in ASD
Carmen Aparicio Samsunlu

Non-evidence based fad treatments
Ayşegül Efe

SYMPOSIUM 25

 

Cannabis Use: Global Perspectives 360°
Moderators:Kültegin Ögel, Mihriban Heval Özgen (Netherlands)

Cannabis Use and Regulations in Netherlands; "Amsterdam Cannabis Cafes and the Dutch Experience"
Mihriban Heval Özgen (Netherlands)

Cannabis use and Recent Regulations in Canada
Serdar Dursun (Canada) (TAP)

Course of cannabis use in Turkey and contribution of cannabidiol to treatment
Cüneyt Evren

Cannabis, harm reduction or total abstinence: Implications for Society, Law and health
Andrew Greenshaw (Canada)

 

SYMPOSIUM 26

 

Cognition and Perception In Psychotic Disorders: New Perspectives
Moderators:Dost Öngür (USA), Serhat Çıtak (TAP)

Visual perception deficits in psychotic disorders and their potential as neurobiological markers
Halide Bilge Turkozer (USA)

Language and gesture in schizophrenia spectrum
Hale Yapici Eser

 

COURSE 11

 

The definition and treatment of treatment-resistant depression
Ali Saffet Gonul

20 April 2019, Saturday

HALL 1

HALL 2

HALL 3

WORKSHOP 7

 

Increasing productivity and efficiency in primary data manuscript writing
Jon Elhai (USA)

WORKSHOP 8

 

Animal Models in Translational Research on Stress- Related Disorders
Benno Roozendaal (Netherlands)

SYMPOSIUM 29

 

A New Disorder That Comes With Technology Age: Internet Addiction
Moderators:Mücahit Öztürk (TAP), Onur Burak Dursun (TAP)

Is Internet Addiction a Clinical Diagnosis?
Gül Karaçetin

Epidemiology and Neurobiology of Internet Addiction
Caner Mutlu

Psychosocial Factors in Internet Addiction
Mehmet Tekden

Treatment of Internet Addiction
Erdem Örnek

 

 

SYMPOSIUM 30

 

Complementary, integrative and culture-based treatments in psychiatry
Moderators: Mesut Çetin (TAP), Xin-Min Li (Canada)

Herbal and complementary therapies in Mediterranean countries
Feyza Aricioglu (TAP)

MDMA (Ecstasy) enhanced psychotherapy in PTSD: review of the evidence
Mihriban Heval Ozgen (Netherlands)

The research and application of acupuncture therapy in depression
Yanqing Tang (China)

South American based complementary treatments in psychiatry and ayahuasca
Andrew Greenshaw (Canada)

 

SYMPOSIUM 31

 

Approach to Autism Spectrum Disorders (ASD): New developments/new treatments
Moderators: Özalp Ekinci, Ayse Rodopman Arman

Signs and symptoms of destructive behaviour in ASD and approach to treatment
Ozalp Ekinci

Signs of anxiety and approach to quality of life in ASD
Serkan Güneş

SYMPOSIUM 35

 

Personalized psychopharmacology: are we ready to implement it?
Moderators: Angelos Halaris (USA), Brian Leonard (Ireland)

Neuroprogression in psychiatric disorders
Angelos Halaris (USA)

Targeted pharmacological interventions to arrest neuroprogression
Brian Leonard (Ireland)

C-reactive protein: Are we ready to introduce it into clinical practice?
Danika Prochaska (USA)

Pharmacogenomics in psychiatric practice: What it can do for us
Katherine Johnson (USA)

 

PLENARY LECTURE 11

 

New approaches for psychiatric treatments: From Theory to Practice
Chairs :Dost Öngür (USA), Mesut Çetin (TAP)

- Ketamine for TRD; 360° review
- Nitropurisside for TR Schizophrenia

Serdar Dursun (Canada) (TAP)
 

PLENARY LECTURE 12

Chairs :Mücahit Öztürk(TAP), Burak Baykara

Comorbidity of Mental Disorders in Individuals with Intellectual Disabilities/Intellectual Developmental Disorders: Services and Gaps in Care
Kerim Munir (USA)
 

DEBATE

 

Is psychodynamic psychotherapy or cognitive behavioral therapy effective in the treatment of depression and anxiety disorders?
Chairs:Erol Göka, Hayrettin Kara

OPPONENT :
Cognitive behavioral therapy is more effective in the treatment of depression and anxiety disorders.

Hakan Türkçapar (TAP)

PROPONENT  :
Psychodynamic therapy is more effective in the treatment of depression and anxiety disorders.

Serhat Çıtak (TAP)

 

SPECIAL SYMPOSIUM

 

RATIONAL DRUG USE SYMPOSIUM
Chairs:Kemal Sayar (TAP), Mücahit Öztürk (TAP)

Is psychiatry at a crossroads in terms of treatment interventions? What should be done besides pharmacotherapy and psychotherapies for effective treatment of psychiatric disorders?
Mesut Çetin (TAP)

Prevention also matters for rational drug use: Tier 1 Services and Current Mental Health Prevention Efforts of the Turkish Ministry of Health
Esra Alataş

SYMPOSIUM 40

 

Speech and language in childhood psychopathologies
Moderators:Elvan İşeri, Koray Karabekiroğlu

Delayed language development: diagnostic and therapeutic approach to the related disorders
Sema Acar

Language and mind in the context of atypical autism
Koray Karabekiroğlu

ADHD and speech and language disorders
Saliha Baykal
 

SYMPOSIUM 44

 

How to transform basic neurobiology into psychiatric practice
Moderators:Andrew Greeshaw (Canada), Kazım Yazıcı

Functional restoration of the brain: White matter matters
Jiming Kong (Canada)

Low field magnetic stimulation as a new neuroprotective approaches for neuropsychiatric disorders: evidence from animal studies
Yanbo Zhang (Canada)

Synaptic plasticity in in ketamine’s anti-depressive effects
Yu Tian Wang (Canada)

Biomaker studies on psychosis
Tao Li (China)

 

PLENARY LECTURE 13

 

Chairs :Yasemen Işık Taner, Onur Burak Dursun (TAP)

The genesis of artistic creativity. Genius genes and autism
Michael Fitzgerald (Ireland)

SYMPOSIUM 45

 

A novel dream model for psychotherapies: Phenomenological Dream Self Model (PDSM)
Moderators:Hayrettin Kara

Psychotherapy, dreams, and theoretical basis of PDSM
Hayrettin Kara

Current neuroscience and PDSM studies about dreams
Sena Yenel

General framework of PDSM: process and technique
Feyza Bağlan

FORUM

 

An international dialogue of collaboration in research: What can we do?
Moderators:Kemal Sayar (TAP), Serdar Dursun (Canada) (TAP)


Opportunities in mental health research at University of Alberta
Xin-Min Li (Canada)

Regional and international collaboration for bipolar disorders: EABF, ANBD, and ISBD
Kyooseob Ha (South Korea)

Potential for multi-site translational research in psychiatry – what are the pitfalls?
Dost Öngür (USA)

International collaboration on using neuroimaging to investigate trajectories of brain changes in schizophrenia
Ali Saffet Gönül
 

SYMPOSIUM 49

 

Evaluation of psychotropic medication related problems in pediatric inpatients
Moderators:Ebru Cengel Kultur, Neslihan Emiroglu

Clinical pharmacy practices and drug related problems
Kutay Demirkan

Psychopharmacology and polypharmacy
Nadir Yalcin

Psychotropic-psychotropic & Psychotropic-drug interactions: Which one is more important in child and adolescent psychiatry?
Halime Tuna Cak Esen

Drug-drug interaction of psychotropic drugs with off-label usage
Nesligul Ozdemir

SYMPOSIUM 50

 

Neuropsychiatric disorders and physical diseases multidisciplinary approach
Moderators:Neşe Kocabaşoğlu, Bülent Bahçeci


The importance of exercise in mental disorders
Selim Polat

Exercise prescriptions in neurological diseases
Tuğba Uyar

Exercise therapy in children and adolescent mental disorders
Selcen Esenyel

AWARD CEREMONY       
 

21 April 2019, Sunday

HALL 1

HALL 2

HALL 3

SYMPOSIUM 54

 

Current approaches to nicotine abuse
Moderators:İbrahim Taymur, Neşe Kocabaşoğlu

Neurobiology of nicotine (cigarette) abuse disorder
Ayşegül Kervancıoğlu 

Cognitive behavior in nicotine (cigarette) abuse disorder psychotherapy
Canan Efe 

Hypnosis in nicotine (cigarette) abuse disorder
Ayşegül Kart 

 

 

SYMPOSIUM 56

 

Complementary treatments in management of ADHD
Moderators:Onur Burak Dursun (TAP), İbrahim Selçuk Esin

Contribution of ergotherapy in treatment of ADHD
Hicran Doğru 
 

SYMPOSIUM 60

 

Recent studies in the field of bipolar disorder
Moderators:Özge Şahmelikoğlu Onur

Cognitive functions in bipolar disorder
Pelin Özkara Menekşeoğlu 

Biological and clinical markers in bipolar disorder
Suat Yalçın 

Metacognitions in Bipolar Disorder
Gülşen Teksin Ünal 

 

 


 

CLOSING REMARKS